Its primary approved indication remains blood sugar regulation in patients with Type 2 diabetes
McGraw-Hill / Lange rxlist.com (Tragenta ) Alogliptin Trade Name: Nesina Mechanism of Action: a DPP-4 inhibitor, similar to Sitagliptin Pharmacokinetics: does not undergo significant metabolism, and is mostly excreted unchanged in the urine (76%) and feces (13%) dosage should be reduced in patients with moderate to severe renal impairment References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)
Semaglutide does not erase the need for healthy habits, but it makes those habits easier to repeat
Intended strictly for laboratory research use
When Combination or Sequential Therapy May Be Appropriate Some patients reach a weight loss plateau on semaglutide alone and benefit from transitioning to tirzepatide to activate additional metabolic pathways
For example, Walmart last week announced it would expand its digital health platform to include weight management care, with the retail giant handling GLP-1 prescription fulfillment
